Viewing Study NCT02116569


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-04-11 @ 3:53 PM
Study NCT ID: NCT02116569
Status: COMPLETED
Last Update Posted: 2016-09-26
First Post: 2014-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
Sponsor: Janssen Pharmaceutical K.K.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module